By Dan Christensen, FloridaBulldog.org
A Miami businessman who once justified his decision to quadruple the price of a liquid antibiotic his company sold – to more than $2,300 a bottle – by asserting a “moral requirement to sell the product at the highest price” has agreed to pay up to $50 million to settle federal Medicaid civil fraud charges.
How much Nirmal Mulye and his company, Nostrum Laboratories, ultimately will have to pay will be based on their financial condition, federal fraud prosecutors said. The minimum amount they owe in the settlement, however, is $3.825 million.
We need your help! If you believe in the value of watchdog journalism please make your tax-deductible contribution today.
We are a 501(c)(3) organization. All donations are tax deductible.
Our mailing address is:
P.O. Box 23763 Fort Lauderdale, FL 33307
Copyright (C) 2023 Florida Bulldog All rights reserved.
Unsubscribe [email protected] from this list (or change email to a different address)
Unsubscribe